Urology: Step-by-Step Guide on How to Write SOAP Notes
Written by SOAPNoteAI Editorial Team · Updated July 2026
Urology documentation spans a wide range of conditions — from benign prostatic hyperplasia and stone disease to urologic oncology and post-surgical follow-up — each with its own scoring systems, exam techniques, and follow-up requirements. Precise SOAP notes are essential for tracking symptom scores over time, justifying imaging and biopsy decisions, and coordinating care between primary care, urology, and oncology when cancer is on the differential.
This guide provides detailed instructions for documenting urology encounters, including symptom scoring (IPSS), the digital rectal exam, PSA interpretation, hematuria workup, catheter management, and common post-operative notes.
Create Your Urology SOAP Note in 2 Minutes
Start with 20 free SOAP notes. No credit card required.
Plans from $29/mo · HIPAA-compliant with signed BAA · 1-click sync to SimplePractice
What Makes Urology Documentation Unique
Urology notes differ from general documentation in several important ways:
- Validated Symptom Scores: Tools like the IPSS and OAB-q require consistent, structured scoring to track treatment response
- Risk-Stratified Workups: Hematuria and elevated PSA both follow guideline-driven risk stratification that must be documented explicitly to justify the chosen workup
- Procedural Volume: High frequency of in-office procedures (catheter placement, cystoscopy, prostate biopsy) each requiring specific documentation elements
- Oncology Staging: Prostate, bladder, and kidney cancer documentation requires staging (TNM) and, for prostate cancer, Gleason/Grade Group reporting
- Longitudinal Tracking: Chronic conditions like BPH and overactive bladder are managed over years, making trend documentation (PSA velocity, IPSS change, post-void residual) especially important
Subjective Section (S)
The Subjective section captures the patient's urinary and reproductive symptoms, their functional impact, and relevant history that shapes the differential diagnosis.
Subjective Section (S) Components
-
Chief Complaint:
- The primary urologic concern in the patient's words
- Example: "I've been getting up 3-4 times a night to urinate and the stream feels weak."
-
History of Present Illness:
- Onset, duration, and progression of urinary symptoms
- Storage symptoms: frequency, urgency, urge incontinence, nocturia (number of episodes)
- Voiding symptoms: hesitancy, weak stream, straining, intermittency, incomplete emptying, post-void dribbling
- Pain: flank pain (constant vs. colicky), suprapubic pain, dysuria, testicular or scrotal pain
- Hematuria: gross vs. microscopic, timing in stream (initial/terminal/total), presence of clots
- Example: "Progressive weak urinary stream and nocturia (3 episodes) over 8 months, now with occasional hesitancy and a sensation of incomplete emptying. Denies dysuria, hematuria, or fever."
-
International Prostate Symptom Score (IPSS), when applicable:
- Score each of the 7 symptom questions (0-5) plus the quality-of-life question (0-6)
- Example: "IPSS 16/35 (moderate), QoL 4/6."
-
Sexual and Reproductive History (when relevant):
- Erectile function (consider IIEF-5 if being formally assessed)
- Ejaculatory symptoms, libido changes
- For fertility/vasectomy visits: prior children, contraception plans, partner discussion
- Example: "Reports mild erectile dysfunction over the past year, IIEF-5 score 18/25 (mild)."
-
Relevant Past Medical/Surgical History:
- Prior UTIs, kidney stones (number, laterality, prior interventions), prior urologic surgery
- Diabetes, neurologic conditions (affecting bladder function), pelvic radiation
- Family history of prostate, bladder, or kidney cancer
- Example: "History of 2 prior kidney stones (both right-sided, treated with lithotripsy). Father with prostate cancer diagnosed at age 68."
-
Medications:
- Alpha-blockers, 5-alpha reductase inhibitors, anticholinergics/beta-3 agonists for OAB
- Anticoagulants/antiplatelets (relevant before any procedure or biopsy)
- PDE5 inhibitors, testosterone therapy
- Example: "Currently on tamsulosin 0.4mg daily for 3 months with partial symptom improvement. Apixaban for atrial fibrillation."
-
Allergies:
- Medication allergies, contrast allergy (relevant for CT urogram)
- Example: "No known drug allergies. No prior contrast reaction."
-
Social History:
- Smoking history (major risk factor for bladder cancer — quantify pack-years)
- Occupational exposures (dyes, chemicals, rubber industry)
- Fluid intake habits, caffeine/alcohol use
- Example: "30 pack-year smoking history, quit 5 years ago. No known occupational chemical exposure."
Example of a Subjective Section for Urology
Objective Section (O)
The Objective section documents measurable urologic findings — vital signs, abdominal and genitourinary exam, laboratory values, and imaging.
Objective Section (O) Components
-
Vital Signs:
- Blood pressure, heart rate, temperature (fever raises concern for pyelonephritis, prostatitis, or Fournier's gangrene)
- Example: "BP 138/84, HR 76, Temp 98.6F"
-
Abdominal Exam:
- Suprapubic tenderness or fullness (suggests urinary retention)
- Costovertebral angle (CVA) tenderness (flank pain workup)
- Palpable bladder, masses
- Example: "Abdomen soft, non-tender, no suprapubic fullness. No CVA tenderness bilaterally."
-
Genitourinary Exam (male):
- External genitalia: testicular size, masses, tenderness, hydrocele, varicocele
- Penile exam: meatal position, plaques (Peyronie's), lesions
- Example: "External genitalia normal. Testes descended bilaterally, no masses or tenderness. No varicocele or hydrocele. No penile lesions or plaques."
-
Digital Rectal Exam (DRE):
- Prostate size, consistency, symmetry, nodules, tenderness
- Sphincter tone, blood on glove
- Example: "Prostate moderately enlarged (~40g), smooth, symmetric, firm without nodules, non-tender. No blood on glove."
-
Laboratory Values:
- PSA (total, and free/total ratio if drawn) with date and prior comparison values
- Urinalysis: specific gravity, leukocyte esterase, nitrites, blood, protein, microscopy (RBC/HPF, WBC/HPF, bacteria, casts)
- Urine culture results if sent
- Creatinine/eGFR (baseline renal function, especially before contrast imaging)
- Example: "PSA 5.8 ng/mL (up from 3.1 ng/mL one year ago). Urinalysis: trace blood, negative leukocyte esterase and nitrites, 2-5 RBC/HPF, no WBCs. Creatinine 1.0 mg/dL (eGFR >60)."
-
Post-Void Residual (PVR):
- Volume in mL, method (bladder scan vs. catheterized)
- Example: "PVR by bladder scan: 85 mL (elevated)."
-
Imaging Findings (when available):
- Renal/bladder ultrasound, CT urogram, or prostate MRI findings with key measurements
- Example: "Renal ultrasound: no hydronephrosis, no renal masses, bladder wall mildly trabeculated, post-void residual 85 mL by ultrasound."
Urology Objective Documentation Template
Example of an Objective Section for Urology
Assessment Section (A)
The Assessment section synthesizes subjective and objective findings into a diagnosis or differential, with explicit risk stratification where guidelines require it.
Assessment Section (A) Components
-
Clinical Diagnosis/Impression:
- Primary diagnosis and severity/stage
- Example: "Benign prostatic hyperplasia with moderate lower urinary tract symptoms (IPSS 16)"
-
Differential Diagnosis (when diagnosis is not yet established):
- Example: "Elevated PSA with rising velocity — differential includes BPH, prostatitis, and prostate cancer"
-
Risk Stratification (guideline-driven):
- For hematuria: low/intermediate/high risk per AUA microhematuria guidance
- For elevated PSA: age-adjusted context, velocity, free/total ratio
- Example: "PSA velocity concerning (2.7 ng/mL increase over 1 year); recommend imaging prior to biopsy per AUA guidance rather than immediate biopsy"
-
Staging (for confirmed malignancy):
- TNM staging, Gleason score/Grade Group for prostate cancer
- Example: "Prostate adenocarcinoma, Gleason 3+4 (Grade Group 2), clinical stage T1c"
-
Response to Treatment:
- For chronic conditions being followed longitudinally
- Example: "IPSS improved from 22 to 16 after 3 months of tamsulosin; partial response"
Example of an Assessment Section for Urology
Plan Section (P)
The Plan section documents medications, procedures, referrals, patient education, and follow-up.
Plan Section (P) Components
-
Medications:
- Alpha-blockers, 5-ARIs, anticholinergics/beta-3 agonists, PDE5 inhibitors, antibiotics
- Include drug, dose, frequency, and monitoring parameters
- Example: "Continue tamsulosin 0.4mg daily. Consider adding a 5-alpha reductase inhibitor if prostate volume confirmed >40g on imaging."
-
Diagnostic Workup Ordered:
- Imaging (renal/bladder ultrasound, CT urogram, multiparametric MRI), cystoscopy, urodynamics
- Repeat labs (PSA recheck interval, urine culture)
- Example: "Order multiparametric prostate MRI. Repeat PSA in 6-8 weeks if MRI is inconclusive."
-
Procedures Performed or Scheduled:
- Catheter placement, cystoscopy, prostate biopsy, lithotripsy, vasectomy
- Example: "Scheduled for in-office cystoscopy in 2 weeks to evaluate bladder for microscopic hematuria workup."
-
Referrals:
- Urologic oncology, nephrology (renal function concerns), radiology for imaging
- Example: "If biopsy confirms malignancy, refer to urologic oncology for treatment options discussion."
-
Patient Education:
- Fluid timing (reducing evening intake for nocturia), bladder training, pelvic floor exercises
- Warning signs requiring urgent evaluation: inability to void, fever with flank pain, gross hematuria with clots
- Example: "Counseled on limiting fluid intake after 6pm to reduce nocturia. Reviewed warning signs of urinary retention and when to seek urgent care."
-
Follow-Up:
- Timing of next visit, result communication plan
- Example: "Follow up in 6-8 weeks to review MRI results and PSA recheck. Sooner if new symptoms develop."
Example of a Plan Section for Urology
AI-Assisted Documentation for Urology
AI-powered documentation tools can meaningfully reduce charting time in a specialty with heavy procedural and scoring-system documentation, but urology's reliance on precise numeric values makes review especially important.
What AI Captures Well in Urology
- Patient-reported symptom history and timeline
- Medication lists and dosing changes
- Patient education and counseling discussions
- Follow-up plans and referral rationale
What Requires Careful Review
- IPSS component scores: verify each of the 7 questions and the total against what was actually stated
- PSA values and dates: confirm the exact number, units, and comparison to prior results
- DRE findings: confirm prostate size estimate, consistency, and nodule location/laterality
- Catheter sizes and procedure details: French size, balloon volume, and any complications must match exactly
Tips for Using AI with Urology Documentation
- State numeric values explicitly: "PSA five point eight nanograms per milliliter" rather than "PSA was elevated"
- Dictate IPSS scores as you go: state the question and score together so the AI captures the pairing correctly
- Confirm laterality: "right kidney stone" rather than "kidney stone" when documenting stone disease or testicular findings
- Review all objective findings before signing, particularly any value that will drive a biopsy or treatment decision
For more details, see our complete AI-Assisted Documentation Guide.
Telehealth Urology Documentation
Many urology follow-up visits — medication titration checks, post-op check-ins without a wound to examine, and results review — are appropriate for telehealth. Document the telehealth modality, patient location, and explicitly note exam limitations (no DRE, no in-person catheter check, no palpation of scrotal findings), with a plan for in-person follow-up when a physical exam is required. See our full Telehealth SOAP Notes Guide for CMS 2026 documentation requirements.
Free Urology SOAP Note Template
More Template Resources
- Free SOAP Note Templates - Download templates for all specialties
- SOAP Note Template Hub - Browse all available templates
Frequently Asked Questions
Document each of the 7 IPSS questions with its 0-5 score (incomplete emptying, frequency, intermittency, urgency, weak stream, straining, nocturia — recorded as number of episodes), the total score out of 35, the severity category (mild 0-7, moderate 8-19, severe 20-35), and the separate quality-of-life score (0-6). Example: 'IPSS total score 14/35 (moderate), QoL score 4 (mostly dissatisfied). Predominant symptoms: weak stream (4/5) and nocturia (3 episodes/night).' Track the score over time to document treatment response.
Document prostate size (estimated in grams or using small/normal/moderately enlarged/markedly enlarged), consistency (firm, boggy, indurated), symmetry, presence or absence of nodules with location if present, tenderness (relevant for prostatitis), sphincter tone, and any blood on the glove. Example: 'DRE: Prostate moderately enlarged (~40g), smooth, symmetric, firm without discrete nodules, non-tender, no blood on glove. Sphincter tone normal.' Always document the exam even when findings are benign, since a normal DRE is clinically relevant to the differential.
Record the PSA value with units (ng/mL), the date of the draw, whether it is total or free/total ratio, and relevant context: patient age, prior PSA values for velocity/trend, whether the patient had recent ejaculation, DRE, catheterization, or UTI that could elevate the result, and current medications (5-alpha reductase inhibitors like finasteride roughly halve PSA and must be accounted for). State the plan explicitly — repeat in 6-8 weeks, free PSA, MRI, or biopsy referral — and the rationale, e.g. 'PSA 5.8 ng/mL, up from 3.1 ng/mL one year ago (velocity concerning). No recent instrumentation or UTI. Plan: multiparametric prostate MRI prior to biopsy decision, per AUA guidance.'
Classify hematuria as gross or microscopic (≥3 RBCs/HPF on a properly collected specimen without a confounding cause), and document whether it is painless or associated with pain, timing (initial, terminal, or total stream for gross hematuria — this localizes the source), risk factors (smoking history, occupational chemical/dye exposure, prior pelvic radiation, cyclophosphamide use, family history, gross hematuria episodes), and workup completed or planned per AUA microhematuria guidelines: urinalysis with microscopy, urine culture to exclude infection, cross-sectional imaging (CT urogram or renal ultrasound depending on risk category), and cystoscopy for intermediate/high-risk patients. Document the risk stratification explicitly since it determines the required workup.
For placement, document indication, catheter type and size (e.g., 16 Fr Foley), technique (sterile, difficulty encountered, use of a coudé tip or guidewire if a difficult catheterization), balloon fill volume, and initial output/character. For ongoing care, document duration in place, output trends, and any signs of infection, bypassing, or encrustation. For complications, document specifics: gross hematuria after traumatic insertion, inability to pass the catheter (and next step — urology consult, suprapubic tube), catheter-associated UTI symptoms, or blockage requiring irrigation or exchange. Example: '16 Fr Foley placed without difficulty after two attempts with a coudé catheter for presumed BPH-related obstruction; balloon inflated to 10 mL with sterile water; immediate output 600 mL clear yellow urine.'
Document the procedure performed, indication, anesthesia type, estimated blood loss, and any intraoperative findings or complications. For TURP: resected tissue weight, irrigation used, catheter size placed and whether continuous bladder irrigation (CBI) was started, and monitoring for TUR syndrome. For vasectomy: technique (no-scalpel vs. incisional), confirmation of vas deferens segments excised bilaterally, and post-procedure instructions (semen analysis timing, alternative contraception until confirmed azoospermia). Include post-op pain control plan, activity restrictions, expected recovery course, and specific return precautions (fever, inability to void, heavy bleeding).
Yes, SOAPNoteAI.com provides AI-assisted documentation designed for healthcare providers across specialties, including urology. It is HIPAA-compliant with a signed Business Associate Agreement (BAA) and works on iPhone, iPad, and web browsers. The AI can capture dictated IPSS scores, DRE findings, PSA discussions, and procedure details into a properly formatted SOAP note, but numeric values like PSA levels, catheter sizes, and IPSS component scores should always be verified against the source before signing.
Medical Disclaimer: This content is for educational purposes only and should not replace professional medical judgment. Always consult current clinical guidelines and your institution's policies.